Bora Pharmaceuticals and Onconic Therapeutics have entered into a manufacturing agreement to support the U.S. clinical development of JAQBO, a potassium-competitive acid blocker (P-CAB)

Dassault Systèmes has signed a definitive agreement to acquire ArisGlobal in a deal valued at approximately US$1.8 billion in cash, with up to an additional US$200 million linked to multi-year AI-related revenue milestones.

Restore Vision has entered into a development and manufacturing partnership with Forge Biologics to support the advancement of RV-001, its investigational adeno-associated virus (AAV) gene therapy

Samsung Biologics has announced an all-cash public tender offer to acquire 100% of the share capital of PolyPeptide Group AG, a global contract development and manufacturing organisation (CDMO) specialising in peptide

Excalipoint Therapeutics has entered into a strategic partnership with DP Technology to co-develop a proprietary artificial intelligence (AI)-powered platform for the discovery of T-cell engagers (TCEs) and multi-specific antibodies.

Samsung Bioepis and Organon have expanded their Development and Commercialisation Agreement to introduce an additional biosimilar product in Australia through Organon ANZ.

Evonik has entered into a partnership with evitria to provide a ready-to-use transient protein expression kit based on Chinese Hamster Ovary (CHO) cells, helping biopharmaceutical researchers accelerate early-stage biologics development.

Pfizer and Astellas Pharma have received approval from the US Food and Drug Administration (FDA) for PADCEV (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab) or Keytruda

Teva Pharmaceuticals and Polpharma Biologics have entered into a global licensing agreement under which Teva will receive exclusive rights to commercialise both intravenous and subcutaneous formulations

Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to expand the use of CASGEVY® (exagamglogene autotemcel) for patients aged two years and older with sickle cell disease